IL141613A0 - Ehrlichia canis 120-kda immunodominant antigenic protein and gene - Google Patents

Ehrlichia canis 120-kda immunodominant antigenic protein and gene

Info

Publication number
IL141613A0
IL141613A0 IL14161399A IL14161399A IL141613A0 IL 141613 A0 IL141613 A0 IL 141613A0 IL 14161399 A IL14161399 A IL 14161399A IL 14161399 A IL14161399 A IL 14161399A IL 141613 A0 IL141613 A0 IL 141613A0
Authority
IL
Israel
Prior art keywords
gene
kda protein
canis
antigenic protein
ehrlichia canis
Prior art date
Application number
IL14161399A
Other languages
English (en)
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL141613A0 publication Critical patent/IL141613A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
IL14161399A 1998-08-27 1999-08-27 Ehrlichia canis 120-kda immunodominant antigenic protein and gene IL141613A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/141,047 US6043085A (en) 1998-08-27 1998-08-27 Ehrlichia canis 120-kDa immunodominant antigenic protein and gene
PCT/US1999/019538 WO2000012688A1 (en) 1998-08-27 1999-08-27 Ehrlichia canis 120-kda immunodominant antigenic protein and gene

Publications (1)

Publication Number Publication Date
IL141613A0 true IL141613A0 (en) 2002-03-10

Family

ID=22493934

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14161399A IL141613A0 (en) 1998-08-27 1999-08-27 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
IL141613A IL141613A (en) 1998-08-27 2001-02-23 Ehrlichia canis 120-kda immunodominant antigenic protein and gene

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141613A IL141613A (en) 1998-08-27 2001-02-23 Ehrlichia canis 120-kda immunodominant antigenic protein and gene

Country Status (17)

Country Link
US (1) US6043085A (xx)
EP (1) EP1108014B1 (xx)
JP (1) JP4550998B2 (xx)
KR (1) KR100652469B1 (xx)
CN (1) CN1281747C (xx)
AT (1) ATE328073T1 (xx)
AU (1) AU764853B2 (xx)
BR (1) BR9913652B1 (xx)
CA (1) CA2340462A1 (xx)
DE (1) DE69931639D1 (xx)
IL (2) IL141613A0 (xx)
MX (1) MXPA01002042A (xx)
NZ (1) NZ510103A (xx)
RU (1) RU2232814C2 (xx)
TW (1) TW557326B (xx)
WO (1) WO2000012688A1 (xx)
ZA (1) ZA200101440B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115840A1 (en) * 1998-11-30 2002-08-22 Walker David H. Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof
US6392023B1 (en) * 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US7335754B2 (en) 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
US6355777B1 (en) * 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
AU2001259304A1 (en) * 2000-05-01 2001-11-12 Research Development Foundation Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
DE60316189T2 (de) * 2002-11-04 2007-12-20 Research Development Foundation, Carson City P153- und p156-antigene zur immundiagnose von ehrlichiose in hunden und menschen und verwendungen davon
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US7842474B2 (en) * 2005-04-04 2010-11-30 Idexx Laboratories, Inc. Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
ES2715280T3 (es) * 2005-04-04 2019-06-03 Idexx Lab Inc DIVA de Erlichia canis (Diferenciación entre Animales Vacunados e Infectados)
US8361480B2 (en) 2007-09-11 2013-01-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Attenuated ehrlichiosis vaccine
MX2010002947A (es) * 2007-09-21 2010-08-04 Idexx Lab Inc Metodos y composiciones para deteccion de ehrlichia chaffeensis (p120).
BRPI0817202B1 (pt) 2007-09-21 2018-11-21 Idexx Lab Inc polipeptídeo purificado e método de detecção de anticorpos que se ligam especificamente a um polipeptídio do ehrlichia chaffeensis em uma amostra em teste
EP2045816A1 (en) * 2007-10-01 2009-04-08 Paul Scherrer Institut Fast readout method and swiched capacitor array circuitry for waveform digitizing
CZ2007716A3 (cs) 2007-10-15 2009-04-29 Elmarco S. R. O. Zpusob výroby nanovláken
WO2009059170A2 (en) * 2007-10-31 2009-05-07 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infection from vaccinated animals)
KR101010432B1 (ko) * 2008-08-30 2011-01-21 이영수 여과기
WO2010126993A1 (en) * 2009-04-28 2010-11-04 Research Development Foundation Immunoreactive ehrlichia p120/p140 epitopes and uses thereof
KR101892182B1 (ko) * 2009-11-20 2018-08-24 아박시스, 인크. 에를리키아 항체의 검출을 위한 펩티드, 장치 및 방법
PT2588133T (pt) * 2010-07-02 2018-03-05 Intervet Int Bv Vacina contra ehrlichia canis e métodos associados
EP2906950B1 (en) 2012-10-11 2018-03-21 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
US9442112B2 (en) 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
AU2019311181A1 (en) * 2018-07-27 2021-02-18 Research Development Foundation Chimeric immunogenic polypeptides
WO2021011456A1 (en) * 2019-07-12 2021-01-21 Research Development Foundation Ehrlichia vaccines and immunogenic compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015691A (en) * 1996-05-31 2000-01-18 Research Development Foundation Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis

Also Published As

Publication number Publication date
AU764853B2 (en) 2003-09-04
KR20010072997A (ko) 2001-07-31
KR100652469B1 (ko) 2006-12-01
CN1281747C (zh) 2006-10-25
RU2232814C2 (ru) 2004-07-20
EP1108014B1 (en) 2006-05-31
JP2002523087A (ja) 2002-07-30
IL141613A (en) 2010-05-31
NZ510103A (en) 2004-10-29
JP4550998B2 (ja) 2010-09-22
CN1321190A (zh) 2001-11-07
ZA200101440B (en) 2002-01-30
ATE328073T1 (de) 2006-06-15
WO2000012688A1 (en) 2000-03-09
EP1108014A1 (en) 2001-06-20
AU5586499A (en) 2000-03-21
US6043085A (en) 2000-03-28
DE69931639D1 (en) 2006-07-06
TW557326B (en) 2003-10-11
MXPA01002042A (es) 2002-06-21
BR9913652A (pt) 2001-06-05
BR9913652B1 (pt) 2014-02-18
EP1108014A4 (en) 2004-12-15
CA2340462A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
ZA200101440B (en) Ehrlichia Canis 120-KDA Immunodominant Antigenic Protein and Gene.
AR047347A1 (es) Miembros de la familia cry9 de bacillus
AR096027A2 (es) Proteínas insecticidas quiméricas de bacillus thuringiensis
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
EP2168596A3 (en) Immunisation against chlamydia trachomatis
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
IL140217A0 (en) Particles of hcv envelope proteins: use for vaccination
CA2385325A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
BR9909342A (pt) Vacinas adn adjuvadas
DK0727483T3 (da) Retrovirus fra HIV-gruppen og dens anvendelse
ATE323164T1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
EP1613345A4 (en) COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320
WO1999028439A3 (fr) Erythrovirus et ses applications
ATE543513T1 (de) Anti-coronavirus impfstoff
WO2006113782A3 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
CA2198743A1 (en) Feline infectious peritonitis vaccine
ATE344802T1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
ATE454398T1 (de) Sperm faktoren sequenzen
ATE380823T1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
AU2001239262A1 (en) Haemophilus influenza outer membrane protein and use thereof in vaccination
MXPA01007582A (es) Control de infeccion por virus utilizando proteinas asociadas de replicacion, composiciones y metodos de uso.
NZ512308A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
TH54286B (th) สายพันธุ์ไคเมอริค IBDV ซีโรไทพ์ (serotype chimeric IBDV strains)
TH54286A (th) สายพันธุ์ไคเมอริค IBDV ซีโรไทพ์ (serotype chimeric IBDV strains)